(DBI) Designer Brands - Ratings and Ratios
Footwear, Accessories, Handbags, Retail, E-Commerce
Dividends
| Dividend Yield | 2.41% |
| Yield on Cost 5y | 3.16% |
| Yield CAGR 5y | 18.92% |
| Payout Consistency | 74.2% |
| Payout Ratio | 500.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 88.7% |
| Value at Risk 5%th | 127% |
| Relative Tail Risk | -12.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 21.30 |
| CAGR/Max DD | -0.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.626 |
| Beta | 1.918 |
| Beta Downside | 2.113 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.72% |
| Mean DD | 40.14% |
| Median DD | 39.07% |
Description: DBI Designer Brands November 15, 2025
Designer Brands Inc. (NYSE:DBI) designs, produces, and retails footwear and accessories across the United States and Canada through three operating segments-U.S. Retail, Canada Retail, and Brand Portfolio. Its product mix includes dress, casual, and athletic shoes, as well as handbags for men, women, and children, sold under proprietary labels such as Vince Camuto, Keds, Topo, Jessica Simpson, Lucky Brand, Le Tigre, and Hush Puppies, and distributed via DSW Designer Shoe Warehouse, The Shoe Co, Rubino, company-owned stores, e-commerce sites, and mobile apps.
Key recent metrics: FY 2023 revenue was approximately $2.2 billion, with comparable-store sales down about 5 % YoY, reflecting broader discretionary-spending pressure; however, e-commerce sales grew roughly 12 % year-over-year, outpacing the brick-and-mortar decline. The company carries a debt-to-equity ratio near 1.2, and its operating margin hovered around 5 % after a modest cost-restructuring effort. Sector-wide, consumer-price inflation and a tightening labor market remain primary drivers of foot-traffic volatility for apparel retailers.
For a deeper dive into DBI’s valuation metrics and scenario analysis, you may find ValueRay’s research platform useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-31.8m TTM) > 0 and > 6% of Revenue (6% = 175.0m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 2.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.12% (prev 5.85%; Δ 0.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 61.4m > Net Income -31.8m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (48.7m) change vs 12m ago -16.90% (target <= -2.0% for YES) |
| Gross Margin 48.19% (prev 31.44%; Δ 16.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.0% (prev 145.2%; Δ -5.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.47 (EBITDA TTM -2.69m / Interest Expense TTM 71.1m) >= 6 (WARN >= 3) |
Altman Z'' 1.22
| (A) 0.09 = (Total Current Assets 751.9m - Total Current Liabilities 573.5m) / Total Assets 2.06b |
| (B) 0.03 = Retained Earnings (Balance) 66.5m / Total Assets 2.06b |
| (C) -0.02 = EBIT TTM -33.4m / Avg Total Assets 2.08b |
| (D) 0.63 = Book Value of Equity 1.11b / Total Liabilities 1.78b |
| Total Rating: 1.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.73
| 1. Piotroski 3.50pt |
| 2. FCF Yield 2.87% |
| 3. FCF Margin 1.49% |
| 4. Debt/Equity 4.70 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC (= -6.90)% |
| 7. RoE -11.10% |
| 8. Rev. Trend -81.99% |
| 9. EPS Trend -49.94% |
What is the price of DBI shares?
Over the past week, the price has changed by +69.88%, over one month by +107.40%, over three months by +87.18% and over the past year by +60.13%.
Is DBI a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.8 | -42.7% |
| Analysts Target Price | 4.8 | -42.7% |
| ValueRay Target Price | 9.2 | 11.5% |
DBI Fundamental Data Overview December 10, 2025
P/E Forward = 9.5147
P/S = 0.0824
P/B = 0.861
P/EG = 2.61
Beta = 1.022
Revenue TTM = 2.92b USD
EBIT TTM = -33.4m USD
EBITDA TTM = -2.69m USD
Long Term Debt = 509.6m USD (from longTermDebt, last quarter)
Short Term Debt = 164.0m USD (from shortTermDebt, last quarter)
Debt = 1.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.28b USD (from netDebt column, last quarter)
Enterprise Value = 1.52b USD (240.3m + Debt 1.32b - CCE 44.9m)
Interest Coverage Ratio = -0.47 (Ebit TTM -33.4m / Interest Expense TTM 71.1m)
FCF Yield = 2.87% (FCF TTM 43.5m / Enterprise Value 1.52b)
FCF Margin = 1.49% (FCF TTM 43.5m / Revenue TTM 2.92b)
Net Margin = -1.09% (Net Income TTM -31.8m / Revenue TTM 2.92b)
Gross Margin = 48.19% ((Revenue TTM 2.92b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 43.65% (prev 42.96%)
Tobins Q-Ratio = 0.73 (Enterprise Value 1.52b / Total Assets 2.06b)
Interest Expense / Debt = 2.68% (Interest Expense 35.4m / Debt 1.32b)
Taxrate = 23.97% (3.56m / 14.8m)
NOPAT = -25.4m (EBIT -33.4m * (1 - 23.97%)) [loss with tax shield]
Current Ratio = 1.31 (Total Current Assets 751.9m / Total Current Liabilities 573.5m)
Debt / Equity = 4.70 (Debt 1.32b / totalStockholderEquity, last quarter 280.8m)
Debt / EBITDA = -473.8 (out of range, set to none) (Net Debt 1.28b / EBITDA -2.69m)
Debt / FCF = 29.29 (Net Debt 1.28b / FCF TTM 43.5m)
Total Stockholder Equity = 286.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.54% (Net Income -31.8m / Total Assets 2.06b)
RoE = -11.10% (Net Income TTM -31.8m / Total Stockholder Equity 286.2m)
RoCE = -4.20% (EBIT -33.4m / Capital Employed (Equity 286.2m + L.T.Debt 509.6m))
RoIC = -3.17% (negative operating profit) (NOPAT -25.4m / Invested Capital 802.8m)
WACC = 3.74% (E(240.3m)/V(1.56b) * Re(13.08%) + D(1.32b)/V(1.56b) * Rd(2.68%) * (1-Tc(0.24)))
Discount Rate = 13.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.96%
[DCF Debug] Terminal Value 51.49% ; FCFE base≈43.5m ; Y1≈28.6m ; Y5≈13.1m
Fair Price DCF = 3.36 (DCF Value 140.3m / Shares Outstanding 41.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -49.94 | EPS CAGR: -7.10% | SUE: -1.97 | # QB: 0
Revenue Correlation: -81.99 | Revenue CAGR: -3.74% | SUE: 0.08 | # QB: 0
EPS next Year (2027-01-31): EPS=0.10 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+121.6% | Growth Revenue=+2.6%
Additional Sources for DBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle